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Summ~ary 
Although both the CD4 and CD8 molecules enhance antigen responsiveness mediated by the 
T  cell receptor (TCR),  it is not known whether CD4 and CD8 initiate similar or different 
intraceUular signals when they act as coreceptors.  To characterize  the early signals transmitted 
by CD4 and CDS, both CD4 and CDSo~ were expressed in the same murine T cell hybridoma. 
In the double positive transfectants,  CD4 and CD8 associated with equal amounts of p56  Ick 
(Lck), and both molecules enhanced interlenkin 2 (IL-2) production equivalently when cross- 
linked with suboptimal levels of anti-TCR antibody. However, in an in vitro kinase assay, cross- 
linking CD4 initiated fourfold greater kinase activity compared with CD8 eross-linking. In the 
same assay, when CD4 or CD8 was cross-linked  to the TCR, novel phosphorylated proteins 
were found associated with the TCR/CD4 complex but not with the TCR/CD8 complex. 
Consistent  with  this  data,  antiphosphotyrosine immunoblotting revealed  greater  tyrosine 
phosphorylation  ofintracellular substrates after TCIL/CD4 cross-linking compared with TCR/CD8 
cross-linking. Additionally, a specific protein kinase C  inhibitor (RO318220) inhibited CDS- 
mediated enhancement of IL-2 production far more effectively than CD4-mediated enhancement. 
Thus, it appears that CDSot may depend more on a protein kinase C-mediated signaling pathway, 
whereas CD4 may rely on greater tyrosine kinase activation. Such differential signaling via CD4 
and CD8 has implications for thymic ontogeny and T  cell activation. 
C 
D4 and CD8 are nonpolymorphic cell surface glycopro- 
teins expressed on subsets of thymocytes and mature 
peripheral T cells (1, 2). Generally, CD4 is expressed on Th 
cells that recognize Ag in association with class II MHC mol- 
ecules, and CD8 is expressed on CTLs that recognize Ag 
in association with class I MHC molecules (1, 3, 4). CD4 
and CD8 actively participate as coreceptors during T cell sig- 
naling and enhance Ag responsiveness mediated by the TCR 
(5-9). Although both CD4 and CD8 bind to the nonreceptor 
tyrosine kinase p56  kk (l.ck) (10, 11), it is not known whether 
CD4 and CD8 molecules initiate similar or different intra- 
cellular  signals when they function as coreceptors. 
Determining the signals initiated by CD4 and CD8 may 
be important to our understanding of thymocyte differentia- 
tion. Two models have been proposed to explain the mecha- 
nism whereby immature thymocytes differentiate from a stage 
where they express both CD4 and CD8 molecules ("double 
positive") to a mature T cell expressing either CD4 or CD8 
(12, 13). The instruction model proposes that engagement 
of the TCR with either CD4 and CD8 during the double 
positive stage leads to retention of the bound coreceptor and 
loss of the other. This model, which is supported by several 
transgenic mouse studies (14-16),  would seem to require 
differential signaling via the CD4 and CD8 molecules. The 
stochastic model predicts that double positive thymocytes turn 
off CD4 or CD8 randomly and are then sdected if they ex- 
press the correct TCR/coreceptor combination. This model 
would not require differential  signaling by CD4 and CD8 
and some recent studies support this model (17, 18). Ddine- 
ation of the signaling pathways used by CD4 and CD8 and 
determining if they initiate different intracellular signals when 
they act as coreceptors would be crucial to the understanding 
of T cell development and the mechanisms of T cell activa- 
tion. In this report, we address this issue of signaling by CD4 
and CD8o~ and find evidence for differential signaling via the 
two molecules. 
Materials  and Methods 
Cell Lines,  BYDP,  a routine T cell hybridoma  expressing  human 
CD4 and CD8a, was generated  by reu'ovirus-mediated  gene transfer 
of CD4 and CD8 into the By155.6 hybridoma (19, 20). The cell 
line expressing  cytoplasmic  taft-deleted  CD4 (A13) has been previ- 
ously described (21). The HLA-A2-reactive  hybridoma BNK was 
generated  by fusing BW5147 cells with splenocytes  from C57BL/6 
mice immunized  with Jurkat cells transfected  with HLA-A2. BNK- 
expressing  human CD8 was generated  by retrovirus-mediated  gene 
transfer (20). 
Assay  for IL2 Production.  96-wall  plates were coated with rabbit 
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with 1% gelatin for I h at room temperature (RT). After washing, 
varying concentrations of anti-TCR mAb (F23.1) were added and 
incubated  for 1 h at RT. Subsequently,  anti-CD4 or anti-CD8 mAbs 
were added (1 mg/ml final) and incubated for another hour at RT. 
Unbound Abs were removed by washing three times with PBS, 
and T cell hybridomas (5  x  104/well)  were added and stimulated 
in triplicate cultures for 24 h. The amount of Ib2 in the superna- 
rants was assessed  using the Ib2-dependent ceLl  line CTLD20 (19). 
In experiments where the effect of protein  kinase C  inhibitor 
RO318220 (Hoffman-La  Roche, Nutley, NJ) was tested, the assays 
were performed as above in the absence or presence of the drug 
(2 ~g/ml final) during T cell stimulation. 
Stimulation of T  Cell Hybridoma and Thymocytes.  BYDP  cells 
(2  x  107/ml) were incubated in 1.5-ml microfuge tubes with or 
without anti-TCR Ab (F23.1) and anti-CD4 (Leu3a) or anti-CD8 
(Leu2a) Ab (each at 500 ng/ml final) for 10 min on ice. RAM (10 
/~g/ral final)  was added for crosslinking and incubated for a further 
10 min on ice. The cells were then incubated at 370C for 2 rain 
unless otherwise indicated. The cells were pelleted by a pulse spin, 
washed once with PBS containing 0.4 mM NasVO4 and 5 mM 
NaF, and lysed in a buffer containing 1% Brij 96 or 0.5% Triton 
X-100, 50 mM Tris, pH 7.6, 150 mM NaC1, 1 mM Na~VO~, 10 
mM NaF, 10 mM sodium  pyrophosphate,  10 ~g/ml each  of  aprotinin 
and leupeptin, and 2 mM PMSF. After spinning down nuclei, the 
lysates were collected. C57BL/6  thymocytes were isohted from 
3-wk-old mice and cultured for 8 h at 370C. The cells (5  x  106 
thymocytes per sample) were then stimulated with anti-TCR Ab 
(H57) and/or anti-CD4 (GK1.5) or anti-CD8 (53.6.7) mAb as de- 
scribed above. 
Iramunoprecipitations  and In Vitro Kinase Assays.  To the lysates 
from 5 x  106 cell equivalents, 50 Izl of a 50% solution of protein 
A-Sepharose beads was added with or without the addition of anti- 
CD4 or anti-CD8 mAb (500 ngAample). After incubation for 2 h 
at 4~  the beads were washed four times with a buffer containing 
0.1% Brij 96, 20 mM Hepes, pH 7.4, 150 mM NaC1, 1 mM 
Na3VO4, 10  mM  NaF, and  10  ~g/ml each of aprotinin  and 
leupeptin (immunoprecipitate (IP) wash buffer). The beads were 
washed once with the same buffer without the detergent  and 
resuspended in 50/xl of kinase reaction buffer (10 mM MnCIz, 5 
mM Hepes, 5 mM p-nitrophenylphosphate, 10 ~Ci 7-[szP]ATP, 
0.1 mM NasVO4, and 10 ~g/ml each of aprotinin and leupeptin). 
The kinase  reactions  were performed for 2 rain at 30~  and stopped 
by addition of 16 Izl of 4x  sample buffer containing 2-ME (5% 
final). The samples were boiled for 5 rain,  the proteins resolved 
by 6-12%  SDS-PAGE, transferred to Polyvinylideue difluoride 
(PVDF) membranes (Millipore Corp., Bedford, MA), and visual- 
ized by autoradiography. 
Anu'phosphotyrosine  Immunoblotting.  BYDP  ceLls  were stimulated 
with the indicated Abs and 1.5  x  106 cell equivalents  were loaded 
per lane and resolved by 6-10%  SDS-PAGE. The proteins were 
transferred to nitrocellulose and immunoblotted  with antiphos- 
photyrosine Ab 4G10 (Upstate Biotechnology Inc. [UBI], Lake 
Pladd,  NY) and developed by the enhanced chemiluminescence 
(ECL) system  (Amersham  Corp., Arlington Heights, IL). For 4G10 
immunoprecipitations, 107 cell equivalents were incubated with 2 
~g of 4G10 Ab and 50/~1 of protein A-Sepharose  beads (prebound 
with RAM) for 2 h at 4~  After washing with IP wash buffer, 
the bound proteins  were ehtcd from the beads using 10 mM  p-nitro- 
phenylphosphate  for 30 min on ice. The duted proteins  were resolved 
by 6-12% SDS-PAGE and immunoblotted with antiphosphotyro- 
sine Ab as described above. 
Anti-Lck Blotting.  BYDP  or A13 cells (1.5  x  107 per sample) 
were lysed  in Brij 96 detergent and immunoprecipitated  with I.eu3a, 
Leu2a, or isotype-matched  control Ab (each  at 1.25 #g per sample) 
and protein A-Sepharose. The proteins were resolved  by 10% SDS- 
PAGE and immunoblotted  with polyclonal anti-Lck (COOH- 
terminal region) Ab (UBI) and developed by ECL. 
Results and Discussion 
Crosslinhing of  CD4 and CD8 on Thymocytes  Leads to Difl'eren- 
tial Activation of  Lch.  Thymocytes from 3-wk-old C57BL/6 
mice were cultured for 8 h, then activated by crosslinking 
CD4 or CD8 alone or with the TCR for 2 rain. at 37~ 
After immunoprecipitation with protein A-Sepharose, the 
level of activation of Lck associated with CD4 or CD8 was 
assessed by an in vitro kinase assay (Fig. 1). A fourfold greater 
activation of Lck (assessed by in vitro autophosphorylation) 
was observed after CD4 crosslinking (either alone or with 
TCR) compared with CD8 crosslinking.  It has been reported 
that much greater levels of  Lck associate with CD4 than with 
CD8 in double positive thymocytes (22). However, we ob- 
served that after lysis in Brij 96 detergent, there was at most 
a twofold greater association of Lck with CD4 than CD8 
(data not shown). Under these conditions, CD4 crosslinking 
induced fourfold greater kinase activity compared with CD8 
crosslinking. These data suggested that in double positive 
thymocytes, CD4  and CD8 may initiate different signals. 
Comparable Levels of Lck Association with CD4 and CD8 
in the Same Murine T Cell Hybridoma.  Because of the hetero- 
geneity of thymocyte populations and the constitutively ac- 
tivated state of freshly isolated thymocytes, characterization 
of signaling by CD4 and CD8 has been technically difficult. 
To better delineate the early signaling cascade initiated by 
CD4 and CD8, a system was needed where both molecules 
wiU associate with equivalent levels of Lck within the same 
T cell and function comparably as coreceptors as assessed by 
a late activation event (e.g., IL-2 production). For this reason, 
we chose to coexpress CD4 and CDSc~ in a murine T  cell 
hybridoma By155.16, and to evaluate signals initiated via the 
two molecules. By155.16 expresses a TCR that is spedfic for 
Figure  1.  Effect  of CD4 and 
CD8 crosslinlring  in thymocytes. 
Thymocytes  from 3-wk-old 
C57BL/6 mice  were  isohted  and 
stimuhted with  anti-TCR Ab 
(H57) and/or anti-L3T4  or anti- 
Lyt2  Abs for 2 rain at 37~  lysed 
using 1% Brij 96 detergent, and 
immunopr~pitated  with protein 
A-Sepharose  _b~d__s~ In vitro  leinu_~e 
assays were performed  for 2 rain 
at 30~  proteins  were sq~arated 
by SDS-PAGE and visualized  by 
autoradiography. 
728  Differential  Signaling  through CD4 and CD8 Figure 2.  Characterization  of CD4 and CD8 ~pressed in BYDP cells. (A) BYDP cells were stained with F23.1 (anti-TCR), Leu3a (anti-CD4), or 
Leu2a (anti-CDS) Abs, and after addition of FITC-labded goat anti-mouse Ig as a second step reagent, the cells were analyzed by flow cytometry. 
(/3) BYDP  or A13 (hybridomas  e~pressing cytoplasmic  tail-deleted CD4) (1.5 x  10r cells per sample) were lysed  in Brij 96 detergent and immunopre- 
cipitated with anti-CD4, anti-CDS, or control IgG Abs, separated  by SDS-PAGE, and immunoblotted with polyclonal  anti-I.& Ab (UBI) (top). The 
basal kinase activity associated  with CD4 and CD8 was measured  in a parallel experiment (5  x  10  ~ cells/sample) by an in vitro kinase assay (bottom). 
The amount of radioactivity incorporated (determined by ~-scoping) showed  equivalent counts in CD4 and CD8 immunoprecipitates in BYDP and 
background counts in control IgG or with A13 cells. (C) BYDP cells (5  x  104/well)  were stimulated in triplicate in 96-well plates precoated with 
RAM and subsequently  with different concentrations of F23.1 and 1 mg/ml of anti-CD4 or anti-CD8 Abs. The supernatants collected after 24 h 
were tested for the presence of Ib2 using the Ib2-dependent cell line CTLL-20. [3H]Thymidine  incorporation by CTLL cells during the last 4 h of 
a 24-h culture is plotted. 
HLA-DR, and produces IL-2 in response to stimulation with 
cells bearing HLA-DR (19) or after Ab crosslinking of the 
TCP.  (V). 
Double positive transfectants  that expressed equivalent  levels 
of human CD4 and human CD8c~ at the cell surface (BYDP) 
were generated (Fig.  2 A). Immunoprecipitation  of CD4 or 
CD8 from these cells and immunoblotting  for I.ck demon- 
strated that both molecules associated with equivalent  amounts 
of l.ck (Fig. 2 B). An in vitro kinase assay after CD4 or CD8 
immunoprecipitation  showed that equivalent levels of basal 
kinase activity were associated with CD4 and CD8 (Fig. 2 B). 
CD4 and CD8 Function Equi~lently as Coreceptors  for IL-2 
Production.  If T  cells are stimulated by suboptimal concen- 
trations of anti-TCR Ab, crosslinking CD4 or CD8 to the 
TCR will enhance activation (5, 7). When double positive 
transfectants were stimulated with suboptimal levels of anti- 
TCR Ab, crosslinking of either CD4 or CD8 enhanced IL-2 
production equivalently  (5-20-fold compared with crosslinking 
the  anti-TCR  Ab  alone)  (Fig.  2  C).  These  results  were 
confirmed with  several independently derived double posi- 
tive hybridomas.  These data indicated that both molecules 
were able to provide equivalent coreceptor function for IL-2 
production. 
Differential  Effects of  TCR/CD4  vs.  TCR/CD8  Cross- 
linking.  The level of Lck activation after CD4 or CD8 cross- 
linking in the double positive hybridoma was assessed by an 
in vitro kinase assay. After TCR crosslinking alone, or after 
crosslinking CD4 or CD8 to the TCR for 2 rain at 37~ 
cells were lysed in Brij  96,  a mild detergent  that  has been 
shown to preserve molecular complexes associated with TCR, 
CD4, or CD8 (23). Ab erossllnking  of CD4 resulted in fivefold 
greater autophosphoryhtion of Lck compared with CD8 cross- 
Inking  (Fig.  3 A).  Thus,  even though  the double positive 
hybridomas have comparable amounts of Lck bound to CD4 
and CD8, crosslinking CD4 initiated greater Lck kinase ac- 
tivity than  crosslinking  CD8.  We also noted several  novel 
phosphorylated bands that  appeared only after TCR/CD4 
crosslinking, but not after TCR/CD8 crosslinking, nor after 
crosslinking  CD4 alone.  Even after prolonged exposure of 
the autoradiographs,  associated bands were not detected in 
lanes from TCR/CD8-crosslinked  cells (Fig.  3 A).  These 
data suggest that even though both CD4 and CD8 can enhance 
IL-2  production  equivalently,  TCR/CD4  and  TCR/CD8 
crosslinking  may initiate  different  signals. 
The novel bands detected in TCR/CD4 lanes could be due 
to the association of new proteins during TCR/CD4 activa- 
tion, or results from their association with CD4 or TCR./CD3 
chains after lysis. To distinguish between these two alterna- 
tives, anti-CD4 Ab was added to all samples  after activation 
and detergent lysis. Except for the basal l.ck kinase activity 
that was precipitated by the anti-CD4 Ab (seen in all lanes), 
no novel bands appeared in TCR alone or in TCIL/CDS-cross- 
linked lanes.  This suggests that the novel bands reflect pro- 
tdns that associated with TCR/CD3 and/or CD4 chains only 
after activation.  Post-lysis addition of anti-CD8 Ab did not 
result in any novel bands (data not shown). To rule out the 
possibility that these results were unique to the Abs that were 
used,  a panel  of anti-CD4  and anti-CD8  Abs was tested. 
Markedly enhanced Lck activity and novel associated bands 
were seen with all anti-CD4  mAbs used (Leu3a, OKT4C, 
and OKT4D), but with neither of the anti-CD8 mAbs used 
(Len2a and OKT8) (data not shown). T cell hybridomas ex- 
pressing CD4 or CD8 alone revealed patterns of phosphory- 
lation similar to that seen in the double positive hybridomas 
(after CD4 or CD8 crosslinking  alone or with TCR) (data 
not shown). Thus, these results do not appear to be unique 
to double positive cells but rather reflect an inherent  prop- 
erty of CD4 or CD8  signaling.  Transfectants  expressing a 
729  Ravichan&an  and Burakoff  Brief  Definitive Report Figure  3.  Differential activation of Lck after CD4 or CD8 crosslinking and association of novel proteins after TCR/CD4 crosslinking. (A) BYDP 
cells were stimulated with the indicated Abs for 2 min at 37~  lysed in 1% Brij-96, and immunoprecipitated with protein A-Sepharose beads without 
any further addition of antibodies. In vitro kinase assays  were performed, and the proteins resolved  by a 6-12% SDS-PAGE  and visualized  by autoradiog- 
raphy. (Left) Molecular weight standards (arrows, right) bands that were different after CD4 and CD8 crosslinking, fl-scoping indicated fourfold greater 
radioactivity incorporated in the 56-kD band in TCR/CD4 crosslinked lanes compared with TCR/CD8  crosslinking, and a 1.5-fold increase after 
TCR/CD8 crosslinking compared with CD8 crosslinking alone. (B) BYDP cells were stimulated and lysed as in A. After lysis, anti-CD4 Ab (500 
ng/sample) was added to all samples and immunoprecipitated with protein A-Sepharose. In vitro kinase assays and autoradiography were performed 
as above. Radioactive counts in the 56-kD band were fourfold higher in TCR/CD4 or CD4 crosslinked  lanes compared with TCR/CD8 lanes. (Arrows) 
Bands that appear in the TCR/CD4 but not in TCR/CD8 lanes. Fivefold longer exposure of the TC1K/CD8 lane is shown on an adjacent panel. 
Even after this prolonged exposure, the 85- and 190-kD bands were seen only in the TCR/CD4 lanes. (C) BNK-CD8 cells were stimulated with 
the indicated Abs and lysed as above. 500 ng anti-CD8 Ab was added to all samples after lysis, and immunoprecipitation and in vitro kinase assays 
were performed as above. Radioactivity incorporated in the 56-kD band was equivalent in all four lanes. 
cytoplasmic tail-deleted  CD4  (21)  did not  show  the phos- 
phorylation  pattern  of wild-type CD4,  indicating  that ele- 
ments within the cytoplasmic domain of CD4 are necessary 
for  the  observed results  (data  not  shown). 
It is possible that the lower phosphorylation seen after CD8 
crosslinking  may be due  to the activation  of a phosphatase 
by CD8 that downregulated phosphorylation.  If this was the 
case,  then  simultaneous  crosslinking  of CD4  and  CD8  to 
the TCR would lead to a pattern of phosphorylation similar 
to TCR/CD8  crosslinking.  As shown in Fig.  3 B  (lane 5), 
simultaneous  crosslinking  of CD4  and  CD8  to  the  TCR 
resulted in a phosphorylated pattern identical to TCR/CD4 
crosslinking.  Though this does not formally rule out the ac- 
tivation of a phosphatase by CD8 crosslinking, it seems likely 
that CD4 crosslinking initiates greater kinase activity com- 
pared  with  CDS. 
Since the TCR of the BYDP hybridoma is reactive with 
human  class II MHC  molecules,  it  is possible that  the en- 
hanced  activation of Lck and  association  of new  substrates 
with  CD4  compared with  CD8  may have been  skewed by 
the specificity of the TCR.  To assess this possibility, we de- 
rived an HLA-A2-reactive hybridoma (BNK) and generated 
transfectants expressing human CD8. The human CD8 mol- 
ecule expressed in BNK was fully functional  as assessed by 
its association with Lck and by enhancement of IL-2 produc- 
tion when crosslinked to the TCR (data not shown). In vitro 
kinase assays performed after TCR/CD8 crosslinking or CD8 
crosslinking alone resulted in minimal enhancement over the 
basal  Lck kinase  activity  (Fig.  3  C).  Several weakly phos- 
phorylated bands were observed after TCR/CD8  crosslinking 
in BNK, however, the major phosphorylated bands seen after 
TCR/CD4  crosslinking were absent. Thus, it seems unlikely 
that the specificity of the TCIK influences coreceptor signaling. 
To  determine  if  the  enhanced  activation  of  Lck  after 
TCR/CD4  crosslinking,  seen  in  vitro  kinase  assays,  also 
resulted in greater phosphorylation of intracellular substrates 
in vivo, we compared the pattern of tyrosine phosphorylated 
proteins  that appear after TCR/CD4  vs. TCR/CD8  cross- 
linking by immunoblotting with an antiphosphotyrosine Ab 
(4G10). Analysis of total cell lysates with 4G10 showed that, 
whereas TCR/CD8  crosslinking  resulted  in  a marginal in- 
crease in tyrosine phosphorylation of intracellular substrates, 
730  Differential Signaling through  CD4 and CD8 TCR/CD4 crosslinking gave significantly enhanced tyrosine 
phosphorylation of several substrates (Fig. 4 A). The possi- 
bility that CD4 and CD8 cross[inking might enhance tyro- 
sine phosphorylation with different kinetics was ruled out 
by performing a time course experiment to determine the 
appearance of tyrosine phosphorylated substrates (Fig. 4 A). 
Many of the bands that were enhanced by TCR, TCR/CD4, 
or TCR/CD8 crosslinking peaked by 1 min but started to 
disappear after 5 min. Enhancement of tyrosine phosphorylated 
proteins by TCR/CD4 cross[inking was more clearly demon- 
strated by immunoprecipitation with an antiphosphotyro- 
sine Ab followed by release of proteins bound to 4G10 by 
p-nitrophenylphosphate, resolution by SDS-PAGE, and im- 
munoblotting with 4G10.  (Fig.  4 B). 
CD8-mediated,  but Not CD4-mediated Enhancement of lL-2 
Production  Is Sensitive  to a Protein  Kinase C  Inhibitor.  Tyro- 
sine kinase activation is the earliest  known signaling event 
following TCR activation. If the initial onset of tyrosine ki- 
nase activation is inhibited by drugs such as herbimycin or 
genistein, subsequent IL-2 production is prevented (24). To 
determine if TCR/CD8  signaling may depend more on a 
pathway involving protein kinase C, the effect of a specific 
protein kinase C inhibitor, RO318220, on enhancement of 
IL-2 production by CD4 and CD8, was evaluated (Fig.  5). 
RO318220 significantly inhibited the enhancement of IL-2 
production by TCR/CD8 cross[inking, whereas TCR/CD4- 
mediated IL-2 enhancement was far less affected.  Thus, it 
appears  that CD8  may depend more on a protein kinase 
C-mediated signaling pathway whereas CD4-mediated sig- 
naling may have a greater dependence on activation of tyro- 
sine  kinases.  This  is  consistent  with  the  observation  of 
O'Rourke and Mescher (25) that the upregulation of CD8 
avidity for class I MHC, while dependent on initial tyrosine 
kinase activity, is sensitive to staurosporine. In addition, the 
interaction of CD8 with MHC class I also leads to enhanced 
IP3 generation (25). 
In conclusion, CD4 and CD8 crosslinking may initiate 
different signals  in both thymocytes and in a CD4 +  CD8 + 
T  cell hybridoma. Julius et al. (26) have also proposed that 
CD4 + and CD8 + T  cells signal differently. Although both 
molecules depend initially on tyrosine kinase activation, CD8 
may depend more on a protein kinase C-mediated signaling 
pathway, whereas CD4 may rely on greater tyrosine kinase 
activation. Such differential signaling may provide a mecha- 
nism for instructing double positive thymocytes to mature 
into CD4 + or CD8 + single positive thymocytes. It cannot 
be  ruled  out,  however,  that  double  positive  thymocytes 
differentiate stochastically to single positive thymocytes and 
subsequently rely on differential signaling of CD4 vs. CD8. 
8000 
Figure 4.  Comparison  of in vivo tyrosine  phosphorylated  substrates 
after TCR./CD4 or TCR/CD8 crosslinking. (A) BYDP cells (5  x 
10~/0.5 ml) were stimulated  with the indicated  Abs for 1, 5, or 15 min. 
After  washing,  the cells  were  lysed  using  0.5% Triton  X-100. Lysates  from 
1.5  x  106 cell equivalents  were loaded  per lane and resolved  by 6-10% 
SDS-PAGE. After  transfer to nitrocellulose,  the tyrosine-phosphorylated 
proteins were  revealed  using  antiphosphotyrosine  Ab 4G10 and ECL.  (Left) 
Migration  of molecular  weight  standards,  (arrows,  right) prominent  bands 
appearing with TCR/CD4 crossllnking.  (/3) BYDP cells (107) were stimu- 
hted and immunoprecipitated  with antiphosphotyrosine  Ab 4(310 and pro- 
tein A-Sepharose beads. After washing extensively,  the bound proteins 
were elated  from the beads using 10 mM p-nitrophenylphosphate  for 30 
min on ice. The ehted proteins were resolved  by 6-12% SDS-PAGE  and 
immunoblotted  with antiphosphotyrosine  Ab. (Left)  Migration  of  molec- 
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Figure 5.  Effect  of  protein  kinase  C inhibitor  on IL-2  production.  BYDP 
cells were stimulated  as described  in Fig. 2 C with or without 2 #g/ml 
of RO318220, and the supernatants  were tested for the presence of Ib2 
on CTLL-20,  as in Fig. 2 C. (i~) Anti-TCR; (ll) anti-TCR + anti-CD4; 
and ([]) anti-TCR +  anti-CD8. 
731  Ravichandran  and Burakoff  Brief  Definitive Report Since only CD8o~ was expressed in the double positive hy- 
bridoma, it will be important to determine the contribution 
of CDSB to early signaling events. Also, identification of the 
substrates that associate with CD4, as well as further deline- 
ation of CD4 and CD8 signaling pathways, should lead to 
a better understanding of thymic ontogeny and T  cell acti- 
vation. 
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